# NeuroOne to Attend MedInvest’s MedTech, AI & Digital Health Conference on June 3-4, 2025
Canonical URL: https://biopharmsignal.com/news/NMTC/neuroone-to-attend-medinvest-s-medtech-ai-digital-health-conference-on-june-3-4--55cc4dc5
Ticker: NMTC
Company: NeuroOne Medical Technologies
Source: NeuroOne Medical Technologies
Published: 2025-05-29 17:05 EST
## Summary

NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical...

## Article Body
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced its participation in the MedInvest MedTech, AI and Digital Health Conference taking place in San Francisco, CA on June 3-4, 2025.

Dave Rosa, President and CEO of NeuroOne will be meeting with investors during the two-day event that will feature informative panel discussions, keynote talks and corporate presentations on medical devices, imaging technologies, diagnostics, AI/data analytics and digital health.

MedTech, AI & Digital Health Conference Dates: June 3-4, 2025 Location: O’Melveny Conference Center, San Francisco, CA Conference registration: https://www.medinvestconferences.com/register

The MedInvest Conference is a leading conference series in Healthcare and Life Sciences. MedInvest hosts semiannual conferences in Biotech and Pharma and in MedTech, AI, and Digital Health. To learn more or to register, please visit their website: https://www.medinvestconferences.com/

About NeuroOne

NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com .

IR Contact MZ Group – MZ North America NMTC@mzgroup.us
## Recent Company News
- 2025-09-08 20:05 EST — [NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025](https://biopharmsignal.com/news/NMTC/neuroone-to-participate-in-sidoti-small-cap-conference-on-september-17th-and-18t-d0cb5764) — Source: NeuroOne Medical Technologies
- 2025-08-18 12:30 EST — [NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain](https://biopharmsignal.com/news/NMTC/neuroone-receives-fda-510-k-clearance-for-onerf-trigeminal-nerve-ablation-system-b8800223) — Source: NeuroOne Medical Technologies
- 2025-08-14 11:30 EST — [NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%](https://biopharmsignal.com/news/NMTC/neuroone-reports-third-quarter-fiscal-year-2025-financial-results-revenue-increa-2aa62a86) — Source: NeuroOne Medical Technologies
- 2025-07-31 16:12 EST — [NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update](https://biopharmsignal.com/news/NMTC/neuroone-to-report-third-quarter-fiscal-year-2025-financial-results-on-thursday--da73b95a) — Source: NeuroOne Medical Technologies
- 2025-07-31 12:30 EST — [NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time](https://biopharmsignal.com/news/NMTC/neuroone-to-report-third-quarter-fiscal-year-2025-financial-results-on-thursday--4c1f9af8) — Source: NeuroOne Medical Technologies
## Related News
- 2026-07-29 20:05 EST — SERA — [SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF SECOND QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON AUGUST 12, 2026](https://biopharmsignal.com/news/SERA/sera-prognostics-announces-conference-call-and-webcast-of-second-quarter-fiscal--2a2c0c5a)
- 2026-07-29 20:05 EST — VKTX — [Viking Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update](https://biopharmsignal.com/news/VKTX/viking-therapeutics-reports-second-quarter-2026-financial-results-and-provides-c-2f09b8ce)
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)